Thymus Cancer Global Clinical Trials Review, H2, 2012Report Details:Published:November 2012No. of Pages: 99Price: Single U...
- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities /...
Clinical Trial Overview of Stanford University 31Indiana University 32Clinical Trial Overview of Indiana University 32Memo...
Secondary Research 98About GlobalData 98Contact Us 98Disclaimer 98Source 99List of TablesThymus Cancer Therapeutics Market...
Humanitas, 2012* 34Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana UniversitySchool ...
Thymus Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 19Thymus Cancer Therapeutics Market, Global...
Upcoming SlideShare
Loading in …5
×

Thymus Cancer Global Clinical Trials Review, H2, 2012

167 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
167
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
3
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Thymus Cancer Global Clinical Trials Review, H2, 2012

  1. 1. Thymus Cancer Global Clinical Trials Review, H2, 2012Report Details:Published:November 2012No. of Pages: 99Price: Single User License – US$2500Thymus Cancer Global Clinical Trials Review, H2, 2012SummaryGlobalDatas clinical trial report, “Thymus Cancer Global Clinical Trials Review, H2, 2012"provides data on the Thymus Cancer clinical trial scenario. This report provides elementalinformation and data relating to the clinical trials on Thymus Cancer. It includes an overview of thetrial numbers and their recruitment status as per the site of trial conduction across the globe. Thedatabook offers a preliminary coverage of disease clinical trials by their phase, trial status,prominence of the sponsors and also provides briefing pertaining to the number of trials for the keydrugs for treating Thymus Cancer. This report is built using data and information sourced fromproprietary databases, primary and secondary research and in-house analysis by GlobalDatasteam of industry experts.Note: Certain sections in the report may be removed or altered based on the availability andrelevance of data for the indicated disease.Scope- Data on the number of clinical trials conducted in North America, South and Central America,Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, alongwith the clinical trial scenario in BRIC nations- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited andsponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)Reasons to buy- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location,sponsor type and many more
  2. 2. - Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or CompaniesGet your copy of this report @http://www.reportsnreports.com/reports/210596-thymus-cancer-global-clinical-trials-review-h2-2012.htmlMajor points covered in Table of Contents of this report includeTable of ContentsTable of Contents 2List of Tables 4List of Figures 5Introduction 6Thymus Cancer 6Report Guidance 6Clinical Trials by Region 7Clinical Trials by Country 8Top Countries Contributing to Clinical Trials in Asia-Pacific 10Top Countries Contributing to Clinical Trials in Europe 11Top Countries Contributing to Clinical Trials in North America 12Top Countries Contributing to Clinical Trials in Middle East and Africa 13Clinical Trials by BRIC Nations 14Clinical Trials by G7 Nations 15Clinical Trials in G7 Nations by Trial Status 16Clinical Trials by E7 Nations 17Clinical Trials in E7 Nations by Trial Status 18Clinical Trials by Phase 19In Progress Trials by Phase 20Clinical Trials by Trial Status 21Unaccomplished Trials of Thymus Cancer 22Subjects Recruited Over a Period of Time 23Prominent Sponsors 24Top Companies Participating in Thymus Cancer Therapeutics Clinical Trials 26Prominent Drug Comparison 27Clinical Trial Profiles 28Clinical Trial Overview of Top Companies 28Nerviano Medical Sciences S.r.l. 28Clinical Trial Overview of Nerviano Medical Sciences S.r.l. 28Novartis AG 29Clinical Trial Overview of Novartis AG 29ZIOPHARM Oncology, Inc. 30Clinical Trial Overview of ZIOPHARM Oncology, Inc. 30Clinical Trial Overview of Top Universities / Institutes / Hospitals 31Stanford University 31
  3. 3. Clinical Trial Overview of Stanford University 31Indiana University 32Clinical Trial Overview of Indiana University 32Memorial Sloan Kettering Cancer Center 33Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 33Istituto Clinico Humanitas 34Clinical Trial Overview of Istituto Clinico Humanitas 34Indiana University School of Medicine 35Clinical Trial Overview of Indiana University School of Medicine 35Shanghai Chest Hospital 36Clinical Trial Overview of Shanghai Chest Hospital 36Shinshu University 37Clinical Trial Overview of Shinshu University 37Kumamoto University 38Clinical Trial Overview of Kumamoto University 38Valley Health System 39Clinical Trial Overview of Valley Health System 39Tohoku University 40Clinical Trial Overview of Tohoku University 40St. Lukes-Roosevelt Hospital Center 41Clinical Trial Overview of St. Lukes-Roosevelt Hospital Center 41Charite- Universitatsmedizin Berlin 42Clinical Trial Overview of Charite- Universitatsmedizin Berlin 42UCLAs Jonsson Comprehensive Cancer Center 43Clinical Trial Overview of UCLAs Jonsson Comprehensive Cancer Center 43Samsung Medical Center 44Clinical Trial Overview of Samsung Medical Center 44Faculty of Pharmaceutical Sciences, Chulalongkorn University 45Clinical Trial Overview of Faculty of Pharmaceutical Sciences, Chulalongkorn University 45Duke University 46Clinical Trial Overview of Duke University 46University of Wisconsin Madison 47Clinical Trial Overview of University of Wisconsin Madison 47Fox Chase Cancer Center 48Clinical Trial Overview of Fox Chase Cancer Center 48The University of Texas M. D. Anderson Cancer Center 49Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 49Five Key Clinical Profiles 50Appendix 96Abbreviations 96Definitions 96Research Methodology 97
  4. 4. Secondary Research 98About GlobalData 98Contact Us 98Disclaimer 98Source 99List of TablesThymus Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012* 7Thymus Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8Thymus Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*9Thymus Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012* 10Thymus Cancer Therapeutics Clinical Trials, Europe, Top Countries, 2012* 11Thymus Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012* 12Thymus Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 13Thymus Cancer Therapeutics Clinical Trials, BRIC Countries, 2012* 14Thymus Cancer Therapeutics Clinical Trials, G7 Countries, 2012* 15Thymus Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 16Thymus Cancer Therapeutics Clinical Trials, E7 Countries, 2012* 17Thymus Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 18Thymus Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012* 19Thymus Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 20Thymus Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 21Thymus Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012* 22Thymus Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 23Thymus Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 25Thymus Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 26Thymus Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 27Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Nerviano MedicalSciences S.r.l., 2012* 28Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012*29Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ZIOPHARMOncology, Inc., 2012* 30Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University,2012* 31Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University,2012* 32Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial SloanKettering Cancer Center, 2012* 33Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Istituto Clinico
  5. 5. Humanitas, 2012* 34Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana UniversitySchool of Medicine, 2012* 35Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Shanghai ChestHospital, 2012* 36Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Shinshu University,2012* 37Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by KumamotoUniversity, 2012* 38Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Valley HealthSystem, 2012* 39Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Tohoku University,2012* 40Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Lukes-RooseveltHospital Center, 2012* 41Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite-Universitatsmedizin Berlin, 2012* 42Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLAs JonssonComprehensive Cancer Center, 2012* 43Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung MedicalCenter, 2012* 44Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Faculty ofPharmaceutical Sciences, Chulalongkorn University, 2012* 45Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University,2012* 46Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University ofWisconsin Madison, 2012* 47Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fox Chase CancerCenter, 2012* 48Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University ofTexas M. D. Anderson Cancer Center, 2012* 49List of FiguresThymus Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 7Thymus Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8Thymus Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*9Thymus Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012* 10Thymus Cancer Therapeutics Clinical Trials, Europe, Top Countries (%), 2012* 11Thymus Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 12Thymus Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012* 15Thymus Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 16
  6. 6. Thymus Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 19Thymus Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 20Thymus Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 21Thymus Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 23Thymus Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 24Thymus Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 26Thymus Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 27GlobalData Methodology 97Contact: sales@reportsandreports.com for more information.

×